Streptomycin
- TRADE NAME: Streptomycin (Pfizer)
- INDICATIONS: Tuberculosis
- CLASS: Antibiotic, Antibiotic; aminoglycoside, Antimicrobial, Drug-resistant antituberculosis agent
- HALF-LIFE: 2–5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aldesleukin, Aminoglycosides, Atracurium, Bacitracin, Bumetanide, Doxacurium, Ethacrynic Acid, Furosemide, Methoxyflurane, Neostigmine, Non-depolarizing muscle relaxants, Pancuronium, Polypeptide antibiotics, Rocuronium, Succinylcholine, Teicoplanin, Torsemide, Vecuronium
PREGNANCY CATEGORY: D
Aminoglycosides may cause neurotoxicity and/or nephrotoxicity.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric